Affirm slips as investors weigh $750M convertible notes deal and dilution risk
Affirm (AFRM) shares fell about 3% to $61.90 as investors digested the company’s recently announced $750 million convertible senior notes offering. Convertible financings often pressure the stock due to dilution concerns and expected hedging activity tied to the deal.
1) What’s moving the stock
Affirm shares traded lower Wednesday as markets focused on the company’s recently announced plan to issue $750 million of convertible senior notes due 2029. Equity investors often treat convert offerings as near-term negatives because they can introduce potential future share dilution and invite short hedging by investors involved in the convert deal.
2) Deal details investors are reacting to
Affirm said it expects to use net proceeds for general corporate purposes and to repurchase, for cash, a portion of its 0% convertible senior notes due 2026 through separately negotiated transactions with certain holders. That mix—raising new convert capital while simultaneously managing near-term maturities—can be viewed as balance-sheet housekeeping, but it can still weigh on shares in the short run as the market recalibrates around the new security and its conversion mechanics.
3) What to watch next
Traders will be watching for final pricing terms (size, coupon, conversion premium) and any disclosure about the scale of 2026-note repurchases completed alongside the offering. With Affirm’s next earnings report approaching (expected May 7, 2026), investors are also likely to treat today’s move as a sentiment check ahead of results, especially if management commentary intersects with funding costs, credit performance, and consumer demand trends.